Mazzo David J 4
4 · LISATA THERAPEUTICS, INC. · Filed Jan 11, 2024
Insider Transaction Report
Form 4
Mazzo David J
DirectorPresident & CEO
Transactions
- Award
Common Stock
2024-01-09+94,000→ 199,308 total - Tax Payment
Common Stock
2024-01-10$3.00/sh−3,470$10,410→ 175,792 total - Tax Payment
Common Stock
2024-01-09$3.08/sh−7,843$24,156→ 179,262 total - Tax Payment
Common Stock
2024-01-09$3.08/sh−12,203$37,585→ 187,105 total - Award
Stock Option (Right to Buy)
2024-01-09+47,000→ 47,000 totalExercise: $3.08From: 2024-01-09Exp: 2034-01-09→ Common Stock (47,000 underlying)
Footnotes (5)
- [F1]Represents 94,000 restricted stock awards granted under the Issuer's 2018 Equity Incentive Compensation Plan. The restricted stock awards vest in four equal installments, with one-fourth of the shares vesting on the date of grant and an additional one-fourth vesting on each of the first, second and third annual anniversaries of the grant date.
- [F2]Includes 115,850 unvested restricted stock.
- [F3]Shares withheld as payment of a tax liability on vesting of restricted stock.
- [F4]Includes 109,166 unvested restricted stock.
- [F5]One-fourth of the shares underlying the stock options vest immediately on the grant date, with an additional one-fourth vesting on each of the first, second and third anniversaries of the grant date.